Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer

Clinical trial NCT03107780 · TERMINATED

Trial details

NCT number: NCT03107780
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma MGMT-Unmethylated Glioblastoma Recurrent Glioblastoma

Start date: 2018-07-09
Primary completion: 2025-08-15
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.